News › Clinical Practice, Industry News, Patient Care

Efficacy and Safety of Kybella When Used Off-label

August 7, 2019

Calvin T. Sung, MD, et al, of the University of California, Riverside School of Medicine and University of California, Irvine, Department of Dermatology, performed a systematic literature search through PubMed, Cochrane, CINAHL and Web of Science databases, to investigate the safety and efficacy of injectable deoxycholic acid (DCA; Kybella; Allergan) when used off-label to treat fat tissue in areas of the body other than the submental region.
Read more at MedEsthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Asheville Wellness Founder Faces 10 Felony Charges in GLP-1 Case
    • GLP-1 Overdose Case Highlights Telehealth Safety, Compliance Risks
    • SkinMedica launches Regenerative Science Advisory Board
    • AmSpa CEO Reflects on the Sonya Dakar Case
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
Advertisement